SCHEMBL6209625

SCHEMBL6209625

O=C(NC1(C(=O)N2CCC3C2C(=O)CN3S(=O)(=O)c2ccc[nH]c2=O)CCCCC1)c1ccc(-c2cccs2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.35
DPP4 P27487 1/20 0.35
PREP P48147 1/20 0.35
CHRM4 P08173 1/20 0.33
DRD4 P21917 6/20 0.32
DRD2 P14416 5/20 0.32
HTR2A P28223 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
TP53 P04637 2/20 0.32
ALOX15 P16050 2/20 0.32
HTT P42858 2/20 0.32
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
KCNH2 Q12809 2/20 0.32
HDAC3 O15379 1/20 0.32
SLC6A2 P23975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043621 0.85 CTSK (0.39) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL6211640 0.85 KDM4E (0.33) CHRM4KDM4ECTSKCTSLCTSB
SCHEMBL4044150 0.84 MEN1 (0.37) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL4039472 0.83 HDAC1 (0.35) HDAC1DPP4PREPCHRM4KDM4E
SCHEMBL4043991 0.82 HDAC1 (0.35) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL4039814 0.81 HDAC1 (0.36) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL4042382 0.81 HDAC1 (0.35) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL6211156 0.80 CHRM4 (0.41) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL4043068 0.80 HDAC1 (0.36) HDAC1DPP4PREPCHRM4DRD4
SCHEMBL6212349 0.80 CTSK (0.40) DPP4PREPCHRM4DRD4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed